Megestrol Acetate EP Impurity G - Request Quote
Megestrol Acetate EP Impurity G
| SZ CAT No: | SZ-M081008 |
| CAS No | NA |
| Mol.F. | C25H34O4 |
| Mol.Wt. | 398.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Megestrol Acetate EP Impurity G is chemically 2β,6-Dimethyl-3,20-dioxopregna-4,6-dien-17-yl acetate (as per EP). Megestrol Acetate EP Impurity G is supplied with detailed characterization data compliant with regulatory guideline. Megestrol Acetate EP Impurity G can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Megestrol Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Megestrol Acetate EP Impurity G
Purchase Megestrol Acetate EP Impurity G
Megestrol Acetate EP Impurity G suppliers
Megestrol Acetate EP Impurity G manufacturers
Megestrol Acetate EP Impurity G price
Order Megestrol Acetate EP Impurity G
Enquire Megestrol Acetate EP Impurity G
Megestrol Acetate EP Impurity G cost
Megestrol Acetate EP Impurity G Supplier
Megestrol Acetate EP Impurity G Distributor
Megestrol Acetate EP Impurity G for Method Validation
Megestrol Acetate Reference Standard
Megestrol Acetate EP Impurity G for ANDA Filing
Megestrol Acetate EP Impurity G for Forced Degradation Studies
Megestrol Acetate EP Impurity G Identification Standards
Megestrol Acetate EP Impurity G for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.